We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Valdidating Blood Pressure Monitors

By HospiMedica staff writers
Posted on 14 Jul 2005
Following six years of continuous use, a study has validated the accuracy of the ambulatory blood pressure (ABP) monitors of Spacelabs Medical (Issaquah, WA, USA).

The researchers used a simulator to routinely check the accuracy of 15 Spacelabs ABP devices (most were model 90207) in use at the Cardiovascular Risk Clinic at the Western General Hospital in Edinburgh (UK) from 1998-2004. More...
The protocol was designed to test the devices over a range of low, normal, and high pressures. The records were examined to assess the long-term consistency and reliability of the devices.

Out of the 1,920 sets measured, only one was outside the generally accepted limits of the pressure expected from the Spacelabs records with the simulated waveforms, and that one exceeded the limits by only 1 mmHg. The criteria for consistency call for the standard deviation of the systolic, diastolic, and mean arterial pressures recorded to be within 3 mmHg, with at least two-thirds within 2 mmHg. In the test, nearly 90% of the average pressures recorded by any device remained within 2 mmHg of their recordings at successive test intervals. Most differences were less than 1 mmHg.

"At the Western General Hospital each patient referred to the Cardiovascular Risk Clinic has 24-hour ambulatory blood pressure monitoring prior to their first clinical consultation,” explained Sister Gough, a physician at the Cardiovascular Risk Clinic. "Spacelabs ambulatory blood pressure monitors are used exclusively at our clinic. The monitors are programmed to record blood pressure measurements at 30-minute cycles over a 24-hour period and patients are encouraged to continue with their normal daily activities while wearing the monitor. We achieve a monitoring success rate in excess of 95%.”

Maintenance records at the Western General Hospital showed that most blood pressure monitoring devices required breakdown maintenance less than once every three years, with no devices requiring repair more than once a year.





Related Links:
Spacelabs

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Isolation Stretcher
IS 736
Portable Jaundice Management Device
Nymphaea
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.